Pulmonary tuberculosis Respiratory Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
Conditions
Interventions
Patients with determined destructive pulmonary tuberculosis resistance were enrolled in study.
Before surgery was considered, they were treated with antitubercular chemotherapy using
Sponsors
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of pulmonary tuberculosis. 2. Admitted to our clinic between 1999 and 2017. 3. Indications for thoracoplasty.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Presence of cavities in pulmonary tissue (CV+/CV-) determined with CT scan/digital X-ray on discharge from the hospital. 2. Presence of M tuberculosis assessed using AFB smear test of sputum (AFB+/AFB-) using sputum fluorescent microscopy and culture method on discharge from the hospital. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Presence of cavities in pulmonary tissue (CV+/CV-) determined with CT scan/digital X-ray every year for 5 years (1st, 2nd, 3rd, 4th, 5th year) after discharge. 2. Presence of M tuberculosis assessed using AFB smear test of sputum (AFB+/AFB-) using sputum fluorescent microscopy and culture method every year for 5 years (1st, 2nd, 3rd, 4th, 5th year) after discharge. 3. TB relapse assessed by clinical follow-up for up to 5 years (1st, 2nd, 3rd, 4th, 5th year) after discharge. | — |
Countries
Russian Federation
Outcome results
None listed